LABCORP HOLDINGS INC. (LH) Form 8-K — Jul 30, 2026
Labcorp reported second quarter 2026 revenue of $3.73 billion, an increase of 5.8% compared to the prior year, driven by growth in both its Diagnostics Laboratories and Biopharma Laboratory Services segments. Adjusted EPS rose 14.9% to $4.99, reflecting significant margin expansion. Based on the strong performance, the company raised its full-year 2026 guidance, projecting enterprise revenue growth between 5.4% and 6.3% and adjusted EPS between $18.10 and $18.55.
Key figures
- Eps
- 3.64
- Revenue
- 3731100000
- Guidance
- Annual revenue growth 5.4% to 6.3%; Adjusted EPS $18.10 to $18.55
- Net Income
- 298700000
- Total Debt
- 5857600000
- Revenue Yoy
- 5.8%
- Cash Position
- 141800000
- Shares Outstanding
- 82000000
- Adjusted eps
- 4.99
- Free cash flow
- 313900000
- Adjusted eps yoy
- 14.9%
- Dividend per share
- 0.72
- Share repurchases q2
- 353800000
- Repurchase authorization increase
- 1000000000
- Total repurchase authorization remaining
- 1400000000
Price after filing
1 day: -2.3%7 days: +0.7%30 days: +6.6%
Close on the filing date to close N calendar days later (from $314.23). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.